Expand Document  |  Expand Chapter  |  Full TOC  |  Printable HTML version
Stability of Essential Drugs in Tropical Climates: Zimbabwe - EDM Research Series No. 013
(1994; 86 pages) View the PDF document
Table of Contents
View the documentAbbreviations
View the document1. Summary
Open this folder and view contents2. Introduction
Open this folder and view contents3. Study design and methods
View the document4. Results
Open this folder and view contents5. Discussion
Open this folder and view contents6. Conclusions and recommendations
View the documentReferences
Open this folder and view contentsAnnexes
 

Stability of Essential Drugs in Tropical Climates: Zimbabwe - EDM Research Series No. 013

WHO Action Programme on Essential Drugs

Zimbabwe Essential Drugs Action Programme

World Health Organization
Organisation mondiale de la Santé

WHO/DAP/94.16
English only
Distribution: Limited

H. Nazerali1
T. Muchemwa2
H.V. Hogerzeil3

1Zimbabwe Essential Drugs Action Programme, Ministry of Health, Harare, Zimbabwe
2Zimbabwe Regional Drug Control Laboratory, Harare, Zimbabwe
3WHO Action Programme on Essential Drugs

Much research work, particularly in developing countries, at present goes unreported. The reasons for this include the intense competition to publish in the scientific press, and difficulties in matching the research resources of developing countries. The DAP research series was established to provide a forum for the rapid distribution of data and findings relevant to critical areas of drug policy and use. The Action Programme has a firm commitment to national operational research as part of its direct country support. It is also strongly committed to making the findings of such studies widely known and accessible. While every effort is made by the Programme to support studies of the highest possible quality, research skills and resources will vary from country to country. Documents in the DAP research series reflect this variation, and range from reports of very small scale studies, undertaken with minimal resources, to major global research involving substantive financial, scientific and editorial input.

© World Health Organization, 1996

This document is not issued to the general public, and all rights are reserved by the World Health Organization (WHO).

The document may not be reviewed, abstracted, quoted, reproduced or translated, in part or in whole, without the prior written permission of WHO. No part of this document may be stored in a retrieval system or transmitted in any form or by any means - electronic, mechanical or other - without the prior permission of WHO.

The views expressed in documents by named authors are solely the responsibility of those authors.

 

to next section
 
 
The WHO Essential Medicines and Health Products Information Portal was designed and is maintained by Human Info NGO. Last updated: June 25, 2014